Bortezomib-Induced Pulmonary Toxicity: A Case Report and Review of Literature

Prakash Kharel; Deekchha Uprety; Abhinav B. Chandra; Yirui Hu; Anuradha Avinash Belur; Ajay Dhakal

doi:10.1155/2018/2913124

Case Reports in Medicine (Jan 2018)

Bortezomib-Induced Pulmonary Toxicity: A Case Report and Review of Literature

Prakash Kharel,
Deekchha Uprety,
Abhinav B. Chandra,
Yirui Hu,
Anuradha Avinash Belur,
Ajay Dhakal

Affiliations

Prakash Kharel: Department of Hospital Medicine, Geisinger Medical Center, 100 N Academy Ave., Danville, PA 17821, USA
Deekchha Uprety: Renal Division, Brigham and Women’s Hospital, Boston, MA, USA
Abhinav B. Chandra: Yuma Regional Medical Center, Yuma, AZ, USA
Yirui Hu: Center for Health Research, Geisinger Medical Center, 100 N Academy Ave., Danville, PA 17821, USA
Anuradha Avinash Belur: Multi Care Regional Cancer Center, Auburn, WA, USA
Ajay Dhakal: Department of Medicine, Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA

DOI: https://doi.org/10.1155/2018/2913124
Journal volume & issue: Vol. 2018

Abstract

Read online

Bortezomib, a proteasome inhibitor, is an established therapy against multiple myeloma. Bortezomib-induced lung injury, although not appreciated during the introductory time of the medication, has now been highlighted in multiple case reports. The objective of this study is to report a case of bortezomib-induced lung injury, review current literature, and perform exploratory analysis.

Published in Case Reports in Medicine

ISSN: 1687-9627 (Print); 1687-9635 (Online)
Publisher: Hindawi Limited
Country of publisher: United Kingdom
LCC subjects: Medicine
Website: https://www.hindawi.com/journals/crim/

About the journal